Equity

Key Financial Ratios Home > Equity > Corporate Information > Key Financial Ratios

Balaxi Pharmaceuticals LtdIndustry : Trading
BSE Code:532597 NSE Symbol: BALAXI P/E (TTM) :79.88
ISIN Demat:INE618N01014 Div & Yield %:0 EPS (TTM) :7.5
Book Value (RS) :117.0934413 Market Cap (Rs Cr.):652.88 Face Value (RS) :10
    Change Company 
YearsMar 2023Mar 2022Mar 2021Mar 2020Mar 2019
Debt-Equity Ratio0.100.050.050.000.00
Long Term Debt-Equity Ratio0.010.000.000.000.00
Current Ratio2.552.072.413.432.72
Fixed Assets19.9262.72179.11456.301360.00
Inventory145.1510129.00204.40109.950.00
Debtors1.662.022.192.494.97
Interest Cover Ratio45.02198.00138.27184.800.00
PBIDTM (%)21.7119.7923.9820.2517.94
PBITM (%)21.2319.5523.8720.2317.94
PBDTM (%)21.2419.7023.8120.1417.94
CPM (%)15.4814.7317.5214.2714.49
APATM (%)15.0014.4817.4214.2514.49
ROCE (%)27.9337.1555.4058.4396.25
RONW (%)21.6229.0042.4041.1077.71

FOR GRIEVANCE MAIL TO invgrieviss@iseindia.com

BSE EQUITIES : INB011077733 | NSE F&O EQUITIES : INF231077737 | NSE CASH MARKET : INB231077737 | NSE CURRENCY DERIVATIVES : INE231077737 | MCX-SX : INE261077737

ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited], a wholly owned subsidiary of Inter-connected Stock Exchange of India Ltd. (ISE)

© 2013 ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited]. All rights reserved.

Designed, developed & powered by C-MOTS Infotech (ISO 9001:2008 certified)